CLINICAL  ||| S:0 E:9 ||| JJ
BACKGROUND  ||| S:9 E:20 ||| NNP
ANALYSIS  ||| S:20 E:29 ||| NNP
ABOUT  ||| S:29 E:35 ||| NNP
TRANSURETHRAL  ||| S:35 E:49 ||| NNP
ELECTROCOAGULATION  ||| S:49 E:68 ||| NNP
Transurethral  ||| S:68 E:82 ||| NNP
electrocoagulation  ||| S:82 E:101 ||| NNS
( ||| S:101 E:102 ||| -LRB-
TUC ||| S:102 E:105 ||| NNP
)  ||| S:105 E:107 ||| -RRB-
is  ||| S:107 E:110 ||| VBZ
a  ||| S:110 E:112 ||| DT
rare  ||| S:112 E:117 ||| JJ
event  ||| S:117 E:123 ||| NN
but  ||| S:123 E:127 ||| CC
occurs  ||| S:127 E:134 ||| VBZ
in  ||| S:134 E:137 ||| IN
a  ||| S:137 E:139 ||| DT
constant  ||| S:139 E:148 ||| JJ
manner  ||| S:148 E:155 ||| NN
with  ||| S:155 E:160 ||| IN
various  ||| S:160 E:168 ||| JJ
causes  ||| S:168 E:175 ||| NNS
or  ||| S:175 E:178 ||| CC
disorders  ||| S:178 E:188 ||| NNS
and  ||| S:188 E:192 ||| CC
reduces  ||| S:192 E:200 ||| VBZ
patient  ||| S:200 E:208 ||| JJ
quality  ||| S:208 E:216 ||| NN
of  ||| S:216 E:219 ||| IN
life ||| S:219 E:223 ||| NN
.  ||| S:223 E:225 ||| .
So  ||| S:225 E:228 ||| RB
far  ||| S:228 E:232 ||| RB
there  ||| S:232 E:238 ||| EX
have  ||| S:238 E:243 ||| VBP
been  ||| S:243 E:248 ||| VBN
no  ||| S:248 E:251 ||| DT
reports  ||| S:251 E:259 ||| NNS
focusing  ||| S:259 E:268 ||| VBG
on  ||| S:268 E:271 ||| IN
the  ||| S:271 E:275 ||| DT
details  ||| S:275 E:283 ||| NNS
of  ||| S:283 E:286 ||| IN
TUC ||| S:286 E:289 ||| NNP
.  ||| S:289 E:291 ||| .
We  ||| S:291 E:294 ||| PRP
focused  ||| S:294 E:302 ||| VBD
on  ||| S:302 E:305 ||| IN
the  ||| S:305 E:309 ||| DT
clinical  ||| S:309 E:318 ||| JJ
background  ||| S:318 E:329 ||| NN
and  ||| S:329 E:333 ||| CC
related  ||| S:333 E:341 ||| JJ
causes  ||| S:341 E:348 ||| NNS
in  ||| S:348 E:351 ||| IN
cases  ||| S:351 E:357 ||| NNS
of  ||| S:357 E:360 ||| IN
TUC  ||| S:360 E:364 ||| NNP
in  ||| S:364 E:367 ||| IN
our  ||| S:367 E:371 ||| PRP$
institution ||| S:371 E:382 ||| NN
.  ||| S:382 E:384 ||| .
We  ||| S:384 E:387 ||| PRP
identified  ||| S:387 E:398 ||| VBD
76  ||| S:398 E:401 ||| CD
cases  ||| S:401 E:407 ||| NNS
( ||| S:407 E:408 ||| -LRB-
65  ||| S:408 E:411 ||| CD
patients ||| S:411 E:419 ||| NNS
)  ||| S:419 E:421 ||| -RRB-
who  ||| S:421 E:425 ||| WP
underwent  ||| S:425 E:435 ||| VBD
TUC  ||| S:435 E:439 ||| NNP
at  ||| S:439 E:442 ||| IN
Keio  ||| S:442 E:447 ||| NNP
University  ||| S:447 E:458 ||| NNP
Hospital  ||| S:458 E:467 ||| NNP
between  ||| S:467 E:475 ||| IN
April  ||| S:475 E:481 ||| NNP
2001  ||| S:481 E:486 ||| CD
and  ||| S:486 E:490 ||| CC
March  ||| S:490 E:496 ||| NNP
2011 ||| S:496 E:500 ||| CD
.  ||| S:500 E:502 ||| .
We  ||| S:502 E:505 ||| PRP
focused  ||| S:505 E:513 ||| VBD
on  ||| S:513 E:516 ||| IN
patient  ||| S:516 E:524 ||| JJ
background ||| S:524 E:534 ||| NN
,  ||| S:534 E:536 ||| ,
especially  ||| S:536 E:547 ||| RB
with  ||| S:547 E:552 ||| IN
respect  ||| S:552 E:560 ||| NN
to  ||| S:560 E:563 ||| TO
the  ||| S:563 E:567 ||| DT
primary  ||| S:567 E:575 ||| JJ
disease ||| S:575 E:582 ||| NN
,  ||| S:582 E:584 ||| ,
treatment  ||| S:584 E:594 ||| NN
modality ||| S:594 E:602 ||| NN
,  ||| S:602 E:604 ||| ,
use  ||| S:604 E:608 ||| NN
of  ||| S:608 E:611 ||| IN
antiplatelet  ||| S:611 E:624 ||| NN
or  ||| S:624 E:627 ||| CC
anticoagulant  ||| S:627 E:641 ||| JJ
agent ||| S:641 E:646 ||| NN
,  ||| S:646 E:648 ||| ,
timing  ||| S:648 E:655 ||| NN
of  ||| S:655 E:658 ||| IN
TUC ||| S:658 E:661 ||| NNP
,  ||| S:661 E:663 ||| ,
type  ||| S:663 E:668 ||| NN
of  ||| S:668 E:671 ||| IN
electrosurgical  ||| S:671 E:687 ||| JJ
device ||| S:687 E:693 ||| NN
,  ||| S:693 E:695 ||| ,
and  ||| S:695 E:699 ||| CC
the  ||| S:699 E:703 ||| DT
incidence  ||| S:703 E:713 ||| NN
of  ||| S:713 E:716 ||| IN
transfusion ||| S:716 E:727 ||| NN
.  ||| S:727 E:729 ||| .
The  ||| S:729 E:733 ||| DT
primary  ||| S:733 E:741 ||| JJ
disease  ||| S:741 E:749 ||| NN
for  ||| S:749 E:753 ||| IN
TUC  ||| S:753 E:757 ||| NNP
included  ||| S:757 E:766 ||| VBD
bladder  ||| S:766 E:774 ||| JJ
tumor  ||| S:774 E:780 ||| NN
( ||| S:780 E:781 ||| -LRB-
BT ||| S:781 E:783 ||| NNP
)  ||| S:783 E:785 ||| -RRB-
in  ||| S:785 E:788 ||| IN
31  ||| S:788 E:791 ||| CD
cases ||| S:791 E:796 ||| NNS
,  ||| S:796 E:798 ||| ,
benign  ||| S:798 E:805 ||| FW
prostate  ||| S:805 E:814 ||| FW
hyperplasia  ||| S:814 E:826 ||| FW
( ||| S:826 E:827 ||| -LRB-
BPH ||| S:827 E:830 ||| NNP
)  ||| S:830 E:832 ||| -RRB-
in  ||| S:832 E:835 ||| IN
13 ||| S:835 E:837 ||| CD
,  ||| S:837 E:839 ||| ,
prostate  ||| S:839 E:848 ||| JJ
cancer  ||| S:848 E:855 ||| NN
( ||| S:855 E:856 ||| -LRB-
PCa ||| S:856 E:859 ||| NNP
)  ||| S:859 E:861 ||| -RRB-
in  ||| S:861 E:864 ||| IN
13 ||| S:864 E:866 ||| CD
,  ||| S:866 E:868 ||| ,
idiopathic  ||| S:868 E:879 ||| JJ
bladder  ||| S:879 E:887 ||| NN
bleeding  ||| S:887 E:896 ||| NN
in  ||| S:896 E:899 ||| IN
4 ||| S:899 E:900 ||| CD
,  ||| S:900 E:902 ||| ,
periarteritis  ||| S:902 E:916 ||| JJ
nodosa  ||| S:916 E:923 ||| NN
in  ||| S:923 E:926 ||| IN
3 ||| S:926 E:927 ||| CD
,  ||| S:927 E:929 ||| ,
uterine  ||| S:929 E:937 ||| JJ
cervical  ||| S:937 E:946 ||| JJ
cancer  ||| S:946 E:953 ||| NN
in  ||| S:953 E:956 ||| IN
3 ||| S:956 E:957 ||| CD
,  ||| S:957 E:959 ||| ,
and  ||| S:959 E:963 ||| CC
others  ||| S:963 E:970 ||| NNS
in  ||| S:970 E:973 ||| IN
9 ||| S:973 E:974 ||| CD
.  ||| S:974 E:976 ||| .
TUC  ||| S:976 E:980 ||| NNP
after  ||| S:980 E:986 ||| IN
transurethral  ||| S:986 E:1000 ||| JJ
resection  ||| S:1000 E:1010 ||| NNS
( ||| S:1010 E:1011 ||| -LRB-
TUR ||| S:1011 E:1014 ||| NNP
)  ||| S:1014 E:1016 ||| -RRB-
was  ||| S:1016 E:1020 ||| VBD
found  ||| S:1020 E:1026 ||| VBN
in  ||| S:1026 E:1029 ||| IN
38  ||| S:1029 E:1032 ||| CD
cases ||| S:1032 E:1037 ||| NNS
,  ||| S:1037 E:1039 ||| ,
including  ||| S:1039 E:1049 ||| VBG
transurethral  ||| S:1049 E:1063 ||| JJ
resection  ||| S:1063 E:1073 ||| NN
of  ||| S:1073 E:1076 ||| IN
bladder  ||| S:1076 E:1084 ||| JJ
tumor  ||| S:1084 E:1090 ||| NN
( ||| S:1090 E:1091 ||| -LRB-
TURBT ||| S:1091 E:1096 ||| NNP
)  ||| S:1096 E:1098 ||| -RRB-
in  ||| S:1098 E:1101 ||| IN
26  ||| S:1101 E:1104 ||| CD
of  ||| S:1104 E:1107 ||| IN
31  ||| S:1107 E:1110 ||| CD
BT  ||| S:1110 E:1113 ||| NNP
cases  ||| S:1113 E:1119 ||| NNS
and  ||| S:1119 E:1123 ||| CC
transurethral  ||| S:1123 E:1137 ||| JJ
resection  ||| S:1137 E:1147 ||| NN
of  ||| S:1147 E:1150 ||| IN
prostate  ||| S:1150 E:1159 ||| NNS
( ||| S:1159 E:1160 ||| -LRB-
TURP ||| S:1160 E:1164 ||| NNP
)  ||| S:1164 E:1166 ||| -RRB-
in  ||| S:1166 E:1169 ||| IN
12  ||| S:1169 E:1172 ||| CD
of  ||| S:1172 E:1175 ||| IN
13  ||| S:1175 E:1178 ||| CD
BPH  ||| S:1178 E:1182 ||| NN
cases ||| S:1182 E:1187 ||| NNS
.  ||| S:1187 E:1189 ||| .
After  ||| S:1189 E:1195 ||| IN
TURBT ||| S:1195 E:1200 ||| NNP
,  ||| S:1200 E:1202 ||| ,
TUC  ||| S:1202 E:1206 ||| NNP
was  ||| S:1206 E:1210 ||| VBD
performed  ||| S:1210 E:1220 ||| VBN
before  ||| S:1220 E:1227 ||| IN
removal  ||| S:1227 E:1235 ||| NN
of  ||| S:1235 E:1238 ||| IN
a  ||| S:1238 E:1240 ||| DT
urethral  ||| S:1240 E:1249 ||| JJ
catheter  ||| S:1249 E:1258 ||| NN
in  ||| S:1258 E:1261 ||| IN
7  ||| S:1261 E:1263 ||| CD
cases ||| S:1263 E:1268 ||| NNS
,  ||| S:1268 E:1270 ||| ,
and  ||| S:1270 E:1274 ||| CC
after  ||| S:1274 E:1280 ||| IN
removal  ||| S:1280 E:1288 ||| NN
of  ||| S:1288 E:1291 ||| IN
a  ||| S:1291 E:1293 ||| DT
urethral  ||| S:1293 E:1302 ||| JJ
catheter  ||| S:1302 E:1311 ||| NN
in  ||| S:1311 E:1314 ||| IN
19  ||| S:1314 E:1317 ||| CD
cases ||| S:1317 E:1322 ||| NNS
.  ||| S:1322 E:1324 ||| .
With  ||| S:1324 E:1329 ||| IN
regard  ||| S:1329 E:1336 ||| NN
to  ||| S:1336 E:1339 ||| TO
TUC  ||| S:1339 E:1343 ||| VB
associated  ||| S:1343 E:1354 ||| VBN
with  ||| S:1354 E:1359 ||| IN
TURP ||| S:1359 E:1363 ||| NNP
,  ||| S:1363 E:1365 ||| ,
the  ||| S:1365 E:1369 ||| DT
average  ||| S:1369 E:1377 ||| NN
estimated  ||| S:1377 E:1387 ||| VBD
prostate  ||| S:1387 E:1396 ||| JJ
volume  ||| S:1396 E:1403 ||| NN
in  ||| S:1403 E:1406 ||| IN
TUC  ||| S:1406 E:1410 ||| NNP
cases  ||| S:1410 E:1416 ||| NNS
before  ||| S:1416 E:1423 ||| IN
removal  ||| S:1423 E:1431 ||| NN
of  ||| S:1431 E:1434 ||| IN
the  ||| S:1434 E:1438 ||| DT
urethral  ||| S:1438 E:1447 ||| JJ
catheter  ||| S:1447 E:1456 ||| NN
was  ||| S:1456 E:1460 ||| VBD
66.2  ||| S:1460 E:1465 ||| CD
ml ||| S:1465 E:1467 ||| NN
,  ||| S:1467 E:1469 ||| ,
which  ||| S:1469 E:1475 ||| WDT
was  ||| S:1475 E:1479 ||| VBD
significantly  ||| S:1479 E:1493 ||| RB
larger  ||| S:1493 E:1500 ||| JJR
than  ||| S:1500 E:1505 ||| IN
that  ||| S:1505 E:1510 ||| DT
in  ||| S:1510 E:1513 ||| IN
TUC  ||| S:1513 E:1517 ||| NNP
cases  ||| S:1517 E:1523 ||| NNS
after  ||| S:1523 E:1529 ||| IN
removal  ||| S:1529 E:1537 ||| NN
of  ||| S:1537 E:1540 ||| IN
the  ||| S:1540 E:1544 ||| DT
urethral  ||| S:1544 E:1553 ||| JJ
catheter  ||| S:1553 E:1562 ||| NN
( ||| S:1562 E:1563 ||| -LRB-
46.1  ||| S:1563 E:1568 ||| CD
ml ||| S:1568 E:1570 ||| NN
,  ||| S:1570 E:1572 ||| ,
p  ||| S:1572 E:1574 ||| VBG
=  ||| S:1574 E:1576 ||| SYM
0.045 ||| S:1576 E:1581 ||| CD
) ||| S:1581 E:1582 ||| -RRB-
.  ||| S:1582 E:1584 ||| .
TUC  ||| S:1584 E:1588 ||| NNP
after  ||| S:1588 E:1594 ||| IN
the  ||| S:1594 E:1598 ||| DT
radiation  ||| S:1598 E:1608 ||| NN
therapy  ||| S:1608 E:1616 ||| NN
was  ||| S:1616 E:1620 ||| VBD
observed  ||| S:1620 E:1629 ||| VBN
in  ||| S:1629 E:1632 ||| IN
21  ||| S:1632 E:1635 ||| CD
cases ||| S:1635 E:1640 ||| NNS
,  ||| S:1640 E:1642 ||| ,
and  ||| S:1642 E:1646 ||| CC
the  ||| S:1646 E:1650 ||| DT
average  ||| S:1650 E:1658 ||| JJ
time  ||| S:1658 E:1663 ||| NN
from  ||| S:1663 E:1668 ||| IN
the  ||| S:1668 E:1672 ||| DT
radiation  ||| S:1672 E:1682 ||| NN
therapy  ||| S:1682 E:1690 ||| NN
to  ||| S:1690 E:1693 ||| TO
TUC  ||| S:1693 E:1697 ||| NNP
was  ||| S:1697 E:1701 ||| VBD
3.4  ||| S:1701 E:1705 ||| CD
years  ||| S:1705 E:1711 ||| NNS
( ||| S:1711 E:1712 ||| -LRB-
7  ||| S:1712 E:1714 ||| CD
months-10  ||| S:1714 E:1724 ||| CD
years ||| S:1724 E:1729 ||| NNS
) ||| S:1729 E:1730 ||| -RRB-
.  ||| S:1730 E:1732 ||| .
TUC  ||| S:1732 E:1736 ||| NNP
was  ||| S:1736 E:1740 ||| VBD
caused  ||| S:1740 E:1747 ||| VBN
by  ||| S:1747 E:1750 ||| IN
multiple  ||| S:1750 E:1759 ||| JJ
causes  ||| S:1759 E:1766 ||| NNS
or  ||| S:1766 E:1769 ||| CC
disorders ||| S:1769 E:1778 ||| NNS
,  ||| S:1778 E:1780 ||| ,
and  ||| S:1780 E:1784 ||| CC
75 ||| S:1784 E:1786 ||| CD
%  ||| S:1786 E:1788 ||| NN
of  ||| S:1788 E:1791 ||| IN
our  ||| S:1791 E:1795 ||| PRP$
TUC  ||| S:1795 E:1799 ||| NNP
was  ||| S:1799 E:1803 ||| VBD
associated  ||| S:1803 E:1814 ||| VBN
with  ||| S:1814 E:1819 ||| IN
BT ||| S:1819 E:1821 ||| NNP
,  ||| S:1821 E:1823 ||| ,
BPH  ||| S:1823 E:1827 ||| NNP
or  ||| S:1827 E:1830 ||| CC
PCa ||| S:1830 E:1833 ||| JJ
.  ||| S:1833 E:1835 ||| .
TUC  ||| S:1835 E:1839 ||| NNP
associated  ||| S:1839 E:1850 ||| VBN
with  ||| S:1850 E:1855 ||| IN
TURBT  ||| S:1855 E:1861 ||| NNP
frequently  ||| S:1861 E:1872 ||| RB
occurred  ||| S:1872 E:1881 ||| VBN
within  ||| S:1881 E:1888 ||| IN
1  ||| S:1888 E:1890 ||| CD
week  ||| S:1890 E:1895 ||| NN
after  ||| S:1895 E:1901 ||| IN
TURBT  ||| S:1901 E:1907 ||| NNP
but  ||| S:1907 E:1911 ||| CC
was  ||| S:1911 E:1915 ||| VBD
still  ||| S:1915 E:1921 ||| RB
observed  ||| S:1921 E:1930 ||| VBN
after  ||| S:1930 E:1936 ||| IN
1  ||| S:1936 E:1938 ||| CD
month  ||| S:1938 E:1944 ||| NN
following  ||| S:1944 E:1954 ||| VBG
the  ||| S:1954 E:1958 ||| DT
operation ||| S:1958 E:1967 ||| NN
.  ||| S:1967 E:1969 ||| .
All  ||| S:1969 E:1973 ||| DT
TUC  ||| S:1973 E:1977 ||| NN
associated  ||| S:1977 E:1988 ||| VBN
with  ||| S:1988 E:1993 ||| IN
TURP  ||| S:1993 E:1998 ||| NNP
occurred  ||| S:1998 E:2007 ||| VBD
within  ||| S:2007 E:2014 ||| IN
3  ||| S:2014 E:2016 ||| CD
weeks  ||| S:2016 E:2022 ||| NNS
after  ||| S:2022 E:2028 ||| IN
operation ||| S:2028 E:2037 ||| NN
.  ||| S:2037 E:2039 ||| .
The  ||| S:2039 E:2043 ||| DT
average  ||| S:2043 E:2051 ||| JJ
period  ||| S:2051 E:2058 ||| NN
from  ||| S:2058 E:2063 ||| IN
radiation  ||| S:2063 E:2073 ||| NN
therapy  ||| S:2073 E:2081 ||| NN
to  ||| S:2081 E:2084 ||| TO
TUC  ||| S:2084 E:2088 ||| NNP
was  ||| S:2088 E:2092 ||| VBD
3.4  ||| S:2092 E:2096 ||| CD
years  ||| S:2096 E:2102 ||| NNS
( ||| S:2102 E:2103 ||| -LRB-
7  ||| S:2103 E:2105 ||| CD
months-10  ||| S:2105 E:2115 ||| CD
years ||| S:2115 E:2120 ||| NNS
)  ||| S:2120 E:2122 ||| -RRB-
and  ||| S:2122 E:2126 ||| CC
TUC  ||| S:2126 E:2130 ||| NNP
associated  ||| S:2130 E:2141 ||| VBN
with  ||| S:2141 E:2146 ||| IN
radiation  ||| S:2146 E:2156 ||| NN
cystitis  ||| S:2156 E:2165 ||| NNS
could  ||| S:2165 E:2171 ||| MD
occur  ||| S:2171 E:2177 ||| VB
beyond  ||| S:2177 E:2184 ||| IN
5  ||| S:2184 E:2186 ||| CD
years  ||| S:2186 E:2192 ||| NNS
after  ||| S:2192 E:2198 ||| IN
radiation ||| S:2198 E:2207 ||| NN
.  ||| S:2207 E:2209 ||| .
